Sakiko Morimoto Selected Research

12-hydroxy-5,8,10,14,17-eicospentaenoic acid

1/2021	12-Hydroxyeicosapentaenoic acid inhibits foam cell formation and ameliorates high-fat diet-induced pathology of atherosclerosis in mice.
1/2021	ω3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sakiko Morimoto Research Topics

Disease

5	Contact Dermatitis (Eczema, Contact) 01/2022 - 01/2018
4	Inflammation (Inflammations) 01/2021 - 01/2018
1	Atherosclerosis 01/2021
1	Weight Gain 01/2021
1	Infections 01/2019
1	Paramyxoviridae Infections (Parainfluenza) 01/2018
1	Tuberculosis (Tuberculoses) 01/2018

Drug/Important Bio-Agent (IBA)

2	12-hydroxy-5,8,10,14,17-eicospentaenoic acidIBA 01/2021 - 01/2021
2	LipidsIBA 01/2021 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2021
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 01/2018
2	AcidsIBA 01/2020 - 01/2019
1	HaptensIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Linseed Oil (Flaxseed Oil)IBA 01/2021
1	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2020
1	Coconut OilIBA 01/2019
1	mead acidIBA 01/2019
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2018
1	AntigensIBA 01/2018
1	VaccinesIBA 01/2018
1	Eicosapentaenoic AcidIBA 01/2018
1	17,18-epoxy-5,8,11,14-eicosatetraenoic acidIBA 01/2018